| scholarly article | Q13442814 |
| P50 | author | Sin-Hyeog Im | Q39923881 |
| P2093 | author name string | Jung-Joon Min | |
| Yeongjin Hong | |||
| Jung-Eun Kim | |||
| Hyon E Choy | |||
| Jin-A Park | |||
| Michael Szardenings | |||
| Hong-Van Dinh-Vu | |||
| Jin Hai Zheng | |||
| Misun Yun | |||
| Sung-Gyoo Park | |||
| SunHee Park | |||
| Thuy Xuan Phan | |||
| Vu Hong Nguyen | |||
| Won Hwang | |||
| P2860 | cites work | IL-1 is required for tumor invasiveness and angiogenesis | Q28594748 |
| Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages | Q28594887 | ||
| Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors | Q29615665 | ||
| New paradigm for tumor theranostic methodology using bacteria-based microrobot | Q30558192 | ||
| Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma | Q33309291 | ||
| Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha | Q33495169 | ||
| TPL2 kinase regulates the inflammatory milieu of the myeloma niche | Q33714724 | ||
| Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy | Q33731187 | ||
| Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
| Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation | Q33762651 | ||
| Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). | Q33910830 | ||
| Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer | Q33925546 | ||
| Signaling pathways mediated by tumor necrosis factor alpha | Q34045299 | ||
| Clostridium spores for tumor-specific drug delivery | Q34119255 | ||
| Mechanisms of the antitumoral effect of lipid A. | Q34561527 | ||
| Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity | Q34620886 | ||
| A novel balanced-lethal host-vector system based on glmS. | Q34654013 | ||
| Living in the danger zone: innate immunity to Salmonella | Q35703018 | ||
| Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma | Q35745802 | ||
| Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
| Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth | Q35921725 | ||
| Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy | Q36189385 | ||
| Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer | Q36230110 | ||
| Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma | Q36492390 | ||
| The use of clostridial spores for cancer treatment. | Q36565145 | ||
| Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. | Q36625499 | ||
| Salmonella, the host and disease: a brief review | Q36673931 | ||
| Inflammatory cell infiltration of tumors: Jekyll or Hyde | Q36918692 | ||
| Immunological aspects of cancer chemotherapy | Q37039588 | ||
| Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages | Q37119939 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| The caspase-1 inflammasome: a pilot of innate immune responses | Q37263621 | ||
| Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | Q37316867 | ||
| Cytokine expression and cancer detection | Q37402389 | ||
| Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. | Q37424066 | ||
| Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium | Q37451801 | ||
| Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity | Q37677942 | ||
| Inflammasome activation and IL-1β and IL-18 processing during infection | Q37844754 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha | Q39483220 | ||
| Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis | Q39596377 | ||
| CD103 is a hallmark of tumor-infiltrating regulatory T cells | Q39612049 | ||
| Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells | Q39628656 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment | Q40022374 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Cytokines and bacterial infections | Q41115952 | ||
| Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta-converting enzyme-mediated apoptosis | Q41181008 | ||
| A rapid method for the isolation of metastasizing tumour cells from internal organs with the help of isopycnic density-gradient centrifugation in Percoll | Q41491002 | ||
| Intratumoral injection of attenuated Salmonella vaccine can induce tumor microenvironmental shift from immune suppressive to immunogenic | Q43540306 | ||
| Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors | Q43661617 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis | Q43918986 | ||
| Cancer immunotherapy based on killing of Salmonella-infected tumor cells | Q45073489 | ||
| Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation | Q45879277 | ||
| Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment | Q45883842 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity | Q50000257 | ||
| A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer | Q50044950 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| Expression of human IL-1 beta in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo | Q50180383 | ||
| Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. | Q51285268 | ||
| The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. | Q53646174 | ||
| Interleukin-1β–Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen–Induced Tumors | Q62735737 | ||
| Processing of precursor interleukin 1 beta and inflammatory disease | Q68453302 | ||
| Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo | Q69727000 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| P304 | page(s) | 1328-1342 | |
| P577 | publication date | 2015-10-06 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. | |
| P478 | volume | 5 |
| Q40937873 | Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy |
| Q33914020 | Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium |
| Q38850160 | Antimelanoma effect of Salmonella Typhimurium integration host factor mutant in murine model |
| Q64946431 | Bacteria in Cancer Therapeutics: A Framework for Effective Therapeutic Bacterial Screening and Identification. |
| Q91890842 | Bacteria-cancer interactions: bacteria-based cancer therapy |
| Q50333648 | Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions |
| Q41701099 | Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. |
| Q57300412 | Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated |
| Q50317370 | Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella |
| Q58121061 | Co-expression of a Chimeric Protease Inhibitor Secreted by a Tumor-targeted Protects Therapeutic Proteins from Proteolytic Degradation |
| Q89947898 | Development of Oxytolerant Salmonella typhimurium Using Radiation Mutation Technology (RMT) for Cancer Therapy |
| Q54213329 | Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models. |
| Q47126937 | Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy |
| Q92575834 | Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells |
| Q92063552 | Imaging of tumor colonization by Escherichia coli using 18F-FDS PET |
| Q91670549 | Live Attenuated Salmonella enterica Expressing and Releasing Cell-Permeable Bax BH3 Peptide Through the MisL Autotransporter System Elicits Antitumor Activity in a Murine Xenograft Model of Human B Non-hodgkin's Lymphoma |
| Q40163572 | Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection. |
| Q47243767 | Molecular Methods to Analyze the Effect of Proteins Expressed by Salmonella During Its Intracellular Stage |
| Q37112974 | RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy |
| Q33798724 | Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth |
| Q91743156 | Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy |
| Q90618645 | Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy |
| Q28069354 | Targeted Cancer Therapy Using Engineered Salmonella typhimurium |
| Q37697144 | The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 |
| Q90017521 | Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q47587450 | Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin |
Search more.